€57,48 €47,50 excl. VAT
Neuronal Ceroid Lipofuscinosis (NCL) is the name referring to a wide array of degenerative neurological conditions which cause progressive nerve damage, resulting in a loss of mobility and vision, and ultimately death.
10 working days
€5,95 shipping and administration per order (incl. VAT)
Specifications
| Breeds | |
|---|---|
| Gene | |
| Organ | |
| specimen | Swab, Blood EDTA, Blood Heparin, Semen, Tissue |
| Mode of Inheritance | |
| Chromosome | |
| Also known as | |
| Year Published |
General information
Neuronal Ceroid Lipofuscinosis (NCL) is the name referring to a wide array of degenerative neurological conditions which cause progressive nerve damage, resulting in a loss of mobility and vision, and ultimately death. The variant of the disease analysed in this test, known as Neuronal Ceroid Lipofuscinosis 1 (NCL1), is caused by a recessive mutation to the gene PPT1, and is found in the Cane Corso. A closely related variant of NCL1 is found in the Dachshund.
Clinical features
Affected puppies begin presenting with symptoms of NCL at approximately half a year of age. Symptoms include gradual loss of vision and ataxia (loss of coordination), as well as neurological signs such as strabismus (wandering eye), absent menace response and a tilted head. The disease is severe and progressive, and euthanasia is likely to be necessary due to poor quality of life.
Additional information
References
Pubmed ID: 28008682
Omia ID: 1504
Related products
-
- All Breeds
- None
-
- Black Russian Terrier, Rottweiler
- RAB3GAP1
- Nervous system
-
- Bernese Mountain Dog
- SOD1
- Nervous system
-
- Rhodesian Ridgeback
- DIRAS1
- Nervous system
